Life Insurance Corporation of India Re-designation of Senior Management Personnel

Life Insurance Corporation of India (LIC) announced the re-designation of Shri Jose George within its management structure, effective February 09, 2026. Shri George has been moved from Vice Principal to Principal of the Zonal Training Centre, Chennai. This change classifies him as a Senior Management Personnel (SMP). He brings over three decades of experience across administrative and marketing roles within the Corporation.

Senior Management Personnel Re-designation

The Life Insurance Corporation of India (LIC) has officially confirmed a key internal organizational change affecting its leadership team. The announcement, dated February 09, 2026, centers on the re-designation of Shri Jose George.

Change in Role

The specific change involves Shri Jose George moving from his previous role as Vice Principal, Zonal Training Centre, Chennai, to the position of Principal, Zonal Training Centre, Chennai. The Corporation has confirmed that this new role falls under the definition of Senior Management Personnel (SMP) for LIC.

Profile and Experience

Shri Jose George commenced his association with the Life Insurance Corporation of India in 1989, joining as an Assistant Administrative Officer. He holds a Graduate degree in Engineering.

His extensive career spans over three decades within the Corporation. During this period, he has successfully handled various capacities in both administrative and marketing functions across the Southern Zone, Western Zone, and the Central Office. Additionally, he previously served as a Faculty Member at the Zonal Training Centre, Chennai, before taking on the role of Vice Principal at the same center. His official assumption of charge as Principal occurred on February 09, 2026.

Compliance Confirmation

LIC confirms that this event disclosure adheres to all required regulatory filings. Furthermore, the company verified that there are no applicable disclosures of relationships between directors related to this internal appointment.

Source: BSE

Previous Article

GlaxoSmithKline Pharmaceuticals Ltd Crosses INR 1000 Cr in Topline with 8.1% Growth for Q3 FY26

Next Article

Aster DM Healthcare Strong Combined Performance in Q3 FY26 Amidst Merger Progress